Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 3748-3760, October 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petrea, I.
Right arrow Articles by Guéritée, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petrea, I.
Right arrow Articles by Guéritée, N.

Hyperplasia of the Parathyroids and the Pituitary in Rats with Experimental Leydigiomas and Inhibitory Effect of Several Steroids

I. Petrea and N. Guéritée1

Department of Internal Medicine, Griffin Hospital, Derby, Connecticut, 06418

Bilateral orchidectomy performed on 10- to 15-day-old Wistar rats, immediately followed by the homograft of one testis into the splenopancreatic epiploon, resulted 6 months later in leydigiomas at the site of the graft in 100% of the animals. After this latency period, the tumors continued to grow proportionately to time elapsed and were associated with both pituitary microadenomas of the aldehyde-fuchsin-, aldehyde-thionin-periodic acid-Schiff-, and periodic acid-Schiff-positive cells and diffuse hyperplasia of the parathyroids, affecting in particular the chief cells of the latter.

After a 6- or 12-month leydigioma latency period, the rats were given a daily treatment by gavage for 45 days of one or two of the following steroids: Compound A, 17{alpha}-ethynyl, (5{alpha})-androst-2-en, 17ß-ol (17ß-acetate) (5 mg/kg when alone; 2.5 mg/kg when combined); Compound B, 17{alpha}-ethynyl, (5{alpha})-androst-2-en, 17ß-ol (17ß-nicotinate) (always given in combined form at 2 mg/kg); Compound C, 16-oximinoestrone, 3-allyl ether (2 mg/kg when combined). The treatments caused, in various degrees, (a) involution of the leydigiomas until complete disappearance in up to 50% of the cases; (b) recovery of the characteristic morphological pattern of the pituitaries; and (c) cytolysis and interstitial fibrosis in the previously hyperplastic parathyroids.

1 Present address: Clinique Endocrinologique, Faculté de Médecine Pitié-Salpetrière, Hôpital de la Pitié, 75013 Paris, France.

Received 2/17/76. Accepted 7/ 7/76.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.